PCIF1 Antikörper (AA 201-500)
-
- Target Alle PCIF1 Antikörper anzeigen
- PCIF1 (PDX1 C-terminal Inhibiting Factor 1 (PCIF1))
-
Bindungsspezifität
- AA 201-500
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PCIF1 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Phosphorylated CTD-interacting factor 1 protein (201-500AA)
- Isotyp
- IgG
- Top Product
- Discover our top product PCIF1 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- PCIF1 (PDX1 C-terminal Inhibiting Factor 1 (PCIF1))
- Andere Bezeichnung
- PCIF1 (PCIF1 Produkte)
- Synonyme
- C20orf67 antikoerper, 2310022K11Rik antikoerper, F730014I05Rik antikoerper, PDX1 C-terminal inhibiting factor 1 antikoerper, PCIF1 antikoerper, Pcif1 antikoerper
- Hintergrund
-
Background: May play a role in transcription elongation or in coupling transcription to pre-mRNA processing through its association with the phosphorylated C-terminal domain (CTD) of RNAPII largest subunit.
Aliases: bA465L10.1 antibody, C20orf67 antibody, Pcif1 antibody, PCIF1_HUMAN antibody, PDX1 C terminal inhibiting factor 1 antibody, Phosphorylated CTD interacting factor 1 antibody, Phosphorylated CTD-interacting factor 1 antibody
- UniProt
- Q9H4Z3
-